Traumatic Brain Injury (TBI) is a major cause of death and disability in the United States and around the world. In the US alone, an estimated 1.7 million people sustain a traumatic brain injury every year and over 30 percent of all reported injury-related deaths list TBI as a contributing factor. The intent of this conference is to provide attendees with a holistic perspective on the diagnosis, treatment and outcomes associated with traumatic brain injury.
In order to better understand how best to achieve the goal of bringing new therapies to market for TBI, speakers will be presenting novel research in the following areas:
· Outcomes Research
The need for consensus on these key subject areas will drive lively and enlightening discussions.
The two day conference will feature a wide range of TBI experts from academia, industry, military and government. Some of the featured speakers include:
· Andrew Maas, MD, Ph.D., Professor & Chairman, Department of Neurosurgery, University Hospital Antwerp will discuss The potential of Comparative Effectiveness Research in TBI as well as participating in the Classification Track Panel Session
· Geoffrey T. Manley, MD, Ph.D., Professor and Vice Chairman of Neurological Surgery, University of California, San Francisco, Chief of Neurosurgery, San Francisco General Hospital, Co-Director, Brain and Spinal Injury Center (BASIC) will lead the track on Building a Knowledge Network for a New Taxonomy of Traumatic Brain Injury
· Charles Bernick, MD, Associate Medical Director, Lou Ruvo Center for Brain Health, Cleveland Clinic will discuss The Search for the Beginning of Chronic Traumatic Encepholopathy (CTE): The Professional Fighters Brain Health Study (PFBHS)
· Deborah A. Shear, Ph.D., Neuroprotection Section Chief, Brain Trauma Neuroprotection and Neurorestoration Branch, Center for Military Psychiatry and Neuroscience (CMPN), Walter Reed Army Institute of Research will present her work on The Military Approach to Neuroprotection Research for Traumatic Brain Injury: Special Focus on Combination Drug Therapy Development
More than thirty experts in the field will be participating in plenary and panel sessions at this dynamic event. Please visit www.tbiconference.com for the full list of speakers, agenda, and information on how to register to attend.